Subject: Newspaper Clipping - Notice of the 35th Annual General Meeting of the Company
We enclose, in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, a copy of each newspaper clipping of the advertisement published on 30 July 2022 on Notice of 35th Annual General Meeting, Book Closure Period and e-voting information to Members, in Ahmedabad edition of the following newspapers:
Financial Express (English), and
Financial Express (Gujarati)
Please take the same on your record.
Sincerely,
For Hester Biosciences Limited
Vinod Mali
Company Secretary &
Compliance Officer
Enclosure: As above
Attachments
Original Link
Original Document
Permalink
Disclaimer
Hester Biosciences Ltd. published this content on 30 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 July 2022 05:22:01 UTC.
Hester Biosciences Limited is an India-based animal healthcare company. The Company is engaged in providing vaccines, health products and diagnostic laboratory services. The Company operates through four segments: Poultry Healthcare, Animal Healthcare, Petcare, and Others. The Animal Healthcare vaccines include Goat Pox Vaccine, Live Brucella, PPR Vaccine - Nigerian 75/1, and PPR Vaccine - Sungri/96. Its Poultry Healthcare products include Gumboro I, Gumboro I +, Inactivated Chick ND, Inactivated Coryza, Inactivated Coryza+, Inactivated EDS, Inactivated FC3, Inactivated FC4, Inactivated IB, Inactivated IB+, Inactivated IB-H52, Inactivated IBD, Inactivated IBD ND, Inactivated IBD ND EDS, Inactivated ND IB, Inactivated Pullet ND, Live B1, Live B1 M48, Live FP, Live H120, Live Las, Live Las Mas, Live M48, Live R2B, Live S-One, MD-Bivalent HVT+SB1, MD-HVT (FD), and Thermostable ND. Its Petcare products include Cefshot Tazo Injection, Hestacef CV, Hestacef DS, Hestaflam Tablet and Hestaliv.
HESTER BIOSCIENCES LIMITED 